BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 114 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,997,000 | – | 35,074 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 82,800 | $2,468,000 | 3.37% |
| NORTHPOINTE CAPITAL LLC | 123,764 | $4,845,000 | 0.52% |
| EAM Investors, LLC | 78,901 | $3,089,000 | 0.36% |
| Elk Creek Partners, LLC | 83,357 | $3,263,000 | 0.34% |
| TFS CAPITAL LLC | 68,551 | $2,684,000 | 0.26% |
| Ativo Capital Management LLC | 13,075 | $512,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 58,623 | $2,295,000 | 0.13% |
| Hillsdale Investment Management Inc. | 10,480 | $410,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 63,647 | $2,492,000 | 0.10% |
| Palo Alto Investors LP | 50,436 | $1,975,000 | 0.10% |